VOR - Vor Biopharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VOR is currently covered by 7 analysts with an average price target of $8.71. This is a potential upside of $6.21 (248.4%) from yesterday's end of day stock price of $2.5.

Vor Biopharma's activity chart (see below) currently has 29 price targets and 47 ratings on display. The stock rating distribution of VOR is 90.48% BUY and 9.52% HOLD.

Stock Analyst Price Targets - Review

Highest price target for VOR is $8, Lowest price target is $0.4, average price target is $4.23.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 30-Jun-2025. First documented stock forecast 02-Mar-2021.

Currently out of the existing stock ratings of VOR, 19 are a BUY (90.48%), 2 are a HOLD (9.52%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$3

$0.5 (20.00%)

13 days ago
(30-Jun-2025)

0/7 (0%)

$1.38 (85.19%)

Hold

$0.4

$-2.1 (-84.00%)

$11

17 days ago
(26-Jun-2025)

0/4 (0%)

$-0.49 (-55.06%)

Buy

$6

$3.5 (140.00%)

2 months 4 days ago
(09-May-2025)

0/7 (0%)

$5.85 (3900.00%)

Buy

$8

$5.5 (220.00%)

3 months 22 days ago
(21-Mar-2025)

0/5 (0%)

$7.13 (819.54%)

Buy

$5

$2.5 (100.00%)

3 months 22 days ago
(21-Mar-2025)

0/3 (0%)

$4.13 (474.71%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VOR (Vor Biopharma) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on VOR (Vor Biopharma) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on VOR (Vor Biopharma) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on VOR (Vor Biopharma)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 3 price targets and 5 ratings on VOR

Which analyst is the currently most bullish on VOR (Vor Biopharma)?

John Walsh with highest potential upside - $15.79

Which analyst is the currently most reserved on VOR (Vor Biopharma)?

David Nierengarten with lowest potential downside - -$2.1

Vor Biopharma in the News

Vor Bio Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, based on currently available clinical data from its key clinical programs and a challenging fundraising environment, the Board of Directors has approved the initiation of a process to explore a range of strategic...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?